News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Newsfile Corp
NEWS
IN THE PRESS
Press Releases
Ruvidar Effective in the Treatment of Herpes
March 24, 2025
·
9 min read
Press Releases
PlasCred Circular Innovations Inc. Enters Long-Term Renewable Green Condensate Agreement for PlasCred’s Neos Facility
March 24, 2025
·
5 min read
Press Releases
Biophytis Announces New Non-Clinical Data Further Supporting Its Mission to Pioneer the Restoration of Mobility in Patients with Obesity
March 24, 2025
·
4 min read
Press Releases
Adaptimmune Provides Q4 and Full Year 2024 Business Update
March 20, 2025
·
7 min read
Press Releases
Sona Presents Additional Preclinical Data Demonstrating Repeated Ability Of Its Cancer Therapy To Inhibit Tumor Growth In Colorectal Cancer Model
March 19, 2025
·
5 min read
Press Releases
Global Hemp Group Announces Private Placement and Corporate Update
March 18, 2025
·
5 min read
Press Releases
Psyence Biomed Further Strengthens Scientific Advisory Board with Appointment of Dr. Dan J. Stein
March 18, 2025
·
7 min read
Press Releases
Quantum BioPharma Unaware of Any Material Change
March 17, 2025
·
1 min read
Press Releases
Hemostemix’s Pitch to Wall Street: ACP-01 Vascular Dementia Trial will Generate $5,365,000, Capture Data, as a Phase 1 Clinical Trial
March 17, 2025
·
8 min read
Press Releases
Pacylex Pharmaceuticals Announces the First Acute Myeloid Leukemia (AML) Patient Dosed with Zelenirstat In a New Phase 1/2 Clinical Trial
March 17, 2025
·
5 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us